Citadel Advisors’s Tenon Medical Warrant TNONW Stock Holding History
Bought
Maintained
Sold
Other funds holding TNONW
Citadel Advisors's TNONW Position: Q3 2026 in Review
Citadel Advisors reduced its Tenon Medical Warrant (TNONW) stake by 52% in Q3 2026, selling an estimated $310 and leaving 33,574 shares worth $201. The position accounts for ﹤0.01% of the portfolio, ranked #13840.
Citadel Advisors first reported a position in TNONW in Q3 2023 and has held it in 13 quarters since. The position peaked at $3.99K in Q1 2024. 6 funds tracked by Wall St. Rank hold TNONW as of Q3 2026.
- Citadel Advisors held 33,574 shares of Tenon Medical Warrant worth $201 as of Q3 2026.
- Citadel Advisors sold 36,925 Tenon Medical Warrant shares in Q3 2026, an estimated $310.
- Tenon Medical Warrant made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13840 holding.
- Citadel Advisors first reported a position in Tenon Medical Warrant in Q3 2023 and has held it in 13 quarters since.
- Citadel Advisors's Tenon Medical Warrant position peaked at $3.99K in Q1 2024.
- 6 funds tracked by Wall St. Rank held Tenon Medical Warrant as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.